HOUSE-BILL 9077: H.R.9077 - Hormone Health Data and Research Act
AI-Powered Summary
HOUSE-BILL 9077 aims to enhance the understanding and management of perimenopause through mandated studies on hormone variability and testing, specifically targeting the healthcare needs of women experiencing this condition. The legislation addresses major themes in women's health, focusing on improving healthcare access, informed consent, and the right to privacy in medical decision-making. Key provisions include directing the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS) to conduct comprehensive studies, which may lead to evidence-based practices and improved clinical guidelines. The bill requires a report summarizing findings and recommendations, promoting transparency and accountability in women's health research. Implementation will involve collaboration between federal health agencies, with a timeline for study completion and reporting that is yet to be specified. The potential impacts include enhanced healthcare options for women, increased awareness of perimenopause, and implications for individual health autonomy, though concerns about government overreach and the adequacy of studies may arise.
Demographic Impact Analysis
Summary
Overall Constitutional Implications
The bill has significant positive implications for women's health rights, particularly in the context of perimenopause, which is a critical health issue affecting a substantial demographic. By mandating research and evaluation, it aims to enhance healthcare practices and outcomes for women, thereby supporting their constitutional rights to health and equal protection.
Key Individual Rights Affected
- Right to Health Care
- Equal Protection under the Law
Constitutional Provisions
- 14th Amendment - Equal Protection Clause
- 14th Amendment - Right to Privacy (implied)
Potential Constitutional Challenges Or Support
While the bill is likely to be supported for its focus on women's health, challenges may arise regarding the adequacy of representation in research studies. If the findings do not consider diverse populations, it could lead to unequal health outcomes, raising equal protection issues. Ensuring inclusivity in research is crucial to uphold constitutional principles.
Summary
HOUSE-BILL 9077 aims to improve understanding and management of hormone variability in women, particularly during perimenopause. This focus on women's health supports gender equality and the right to healthcare, aligning with constitutional principles. However, careful implementation is necessary to prevent disparities among different demographic groups, ensuring that the bill's benefits are equitably distributed.
Constitutional Analysis
This bill appears to align with constitutional principles. The proposed legislation operates within the established framework of constitutional authority and does not appear to conflict with fundamental rights or the separation of powers.
Analysis generated using AI-powered review of constitutional principles and legal precedents.
Take Action
Text 50409
💡 How to use:
These links will start a conversation with ResistBot. When prompted, mention H.R. 9077 to reference this bill.
Contact Your Representatives
Write to YOUR elected officials about this bill
Rate This Bill
Sign in to save a private rating for this bill and track your civic engagement over time.
Sign In FreeTimeline
May 29, 2026
Bill Introduced
Current
Referred to Committee
June 12, 2026
Last Updated
Ask the Constitutional AI About This Bill
Sign in free to chat with our constitutional analysis AI about this bill — get plain-English explanations, constitutional concerns, and demographic impact estimates personalized to you.
Sign In Free to Chat